Your browser doesn't support javascript.
loading
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
Kinoshita, Hannah; Cooke, Kenneth R; Grant, Melanie; Stanojevic, Maja; Cruz, C Russell; Keller, Michael; Fortiz, Maria Fernanda; Hoq, Fahmida; Lang, Haili; Barrett, A John; Liang, Hua; Tanna, Jay; Zhang, Nan; Shibli, Abeer; Datar, Anushree; Fulton, Kenneth; Kukadiya, Divyesh; Zhang, Anqing; Williams, Kirsten M; Dave, Hema; Dome, Jeffrey S; Jacobsohn, David; Hanley, Patrick J; Jones, Richard J; Bollard, Catherine M.
Affiliation
  • Kinoshita H; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Cooke KR; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC.
  • Grant M; Division of Oncology, Children's National Hospital, Washington, DC.
  • Stanojevic M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Cruz CR; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.
  • Keller M; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Fortiz MF; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Hoq F; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Lang H; Stem Cell Transplantation and Cell Therapy Program, George Washington Cancer Center, Washington, DC.
  • Barrett AJ; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Liang H; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Tanna J; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Zhang N; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Shibli A; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Datar A; Stem Cell Transplantation and Cell Therapy Program, George Washington Cancer Center, Washington, DC.
  • Fulton K; Department of Statistics, The George Washington University, Washington, DC; and.
  • Kukadiya D; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Zhang A; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Williams KM; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Dave H; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Dome JS; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Jacobsohn D; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
  • Hanley PJ; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Jones RJ; Department of Pediatric Hematology/Oncology, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA.
  • Bollard CM; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.
Blood Adv ; 6(8): 2520-2534, 2022 04 26.
Article in En | MEDLINE | ID: mdl-35244681
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Country of publication: